Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A-Reference-Cited by-同舟云学术

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

Published:2017-12-19 Issue:1 Volume:18 Page:87-94
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Raso Simona¹²,Hermans Cedric¹

Affiliation:

1. Haemostasis and Thrombosis Unit, Division of Haematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

2. Division of Haematology, Biomedical Department of Internal Medicine and Specialties (DiBiMIS), Paolo Giaccone Hospital, University of Palermo, Palermo, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1416088

Reference61 articles.

1. The History of Hemophilia

2. Hemophilia A in the third millennium

3. Prophylactic therapy for haemophilia: early experience

4. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens

5. A survey of adherence to haemophilia therapy in six European countries: results and recommendations

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A;Haemophilia;2024-08-20

2. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis;eBioMedicine;2024-02

3. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis;2023-05-05

4. Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy;Journal of Medical Economics;2023-04-12

5. Is there any place for replacement therapy of hemophilia A in children in present and future?;Russian Journal of Pediatric Hematology and Oncology;2022-11-09